Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-26.43%
operating margin TTM
8.78%
revenue TTM
2.50 Billion
revenue per share TTM
92.78$
valuation ratios | |
|---|---|
| pe ratio | -12.15 |
| peg ratio | 0.04 |
| price to book ratio | 1.22 |
| price to sales ratio | 3.22 |
| enterprise value multiple | -11.64 |
| price fair value | 1.22 |
profitability ratios | |
|---|---|
| gross profit margin | 52.26% |
| operating profit margin | 8.78% |
| pretax profit margin | -32.95% |
| net profit margin | -26.43% |
| return on assets | -6.97% |
| return on equity | -9.97% |
| return on capital employed | 2.45% |
liquidity ratios | |
|---|---|
| current ratio | 5.44 |
| quick ratio | 5.44 |
| cash ratio | 0.76 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 67.68 |
| days of payables outstanding | 38.51 |
| cash conversion cycle | 29.17 |
| receivables turnover | 5.39 |
| payables turnover | 9.48 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.14 |
| debt equity ratio | 0.21 |
| long term debt to capitalization | 0.15 |
| total debt to capitalization | 0.17 |
| interest coverage | 4.57 |
| cash flow to debt ratio | 0.35 |
cash flow ratios | |
|---|---|
| free cash flow per share | 12.51 |
| cash per share | 52.77 |
| operating cash flow per share | 18.25 |
| free cash flow operating cash flow ratio | 0.69 |
| cash flow coverage ratios | 0.35 |
| short term coverage ratios | 12.90 |
| capital expenditure coverage ratio | 3.18 |
Frequently Asked Questions
When was the last time Bio-Rad Laboratories, Inc. (NYSE:BIO-B) reported earnings?
Bio-Rad Laboratories, Inc. (BIO-B) published its most recent earnings results on 29-10-2025.
What is Bio-Rad Laboratories, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Bio-Rad Laboratories, Inc. (NYSE:BIO-B)'s trailing twelve months ROE is -9.97%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Bio-Rad Laboratories, Inc. (BIO-B) currently has a ROA of -6.97%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did BIO-B's net profit margin stand at?
BIO-B reported a profit margin of -26.43% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is BIO-B's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 5.44 in the most recent quarter. The quick ratio stood at 5.44, with a Debt/Eq ratio of 0.21.